Prescription drug · ANDA
Doxycycline Hyclate NDC 72578-001
Doxycycline hyclate 100 mg/1 · Tablet · Oral · Viona Pharmaceuticals Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72578-001-01 | 72578000101 | 100 TABLET in 1 BOTTLE (72578-001-01)Marketed from Mar 14, 2019 | |
| 72578-001-05 | 72578000105 | 500 TABLET in 1 BOTTLE (72578-001-05)Marketed from Mar 14, 2019 | |
| 72578-001-10 | 72578000110 | 1000 TABLET in 1 BOTTLE (72578-001-10)Marketed from Mar 14, 2019 | |
| 72578-001-18 | 72578000118 | 50 TABLET in 1 BOTTLE (72578-001-18)Marketed from Mar 14, 2019 | |
| 72578-001-77 | 72578000177 | 10 BLISTER PACK in 1 CARTON (72578-001-77) / 10 TABLET in 1 BLISTER PACK (72578-001-30)Marketed from Mar 14, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Doxycycline Hyclate
- Generic name (nonproprietary)
- doxycycline hyclate
- Active ingredients
- Doxycycline hyclate — 100 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Viona Pharmaceuticals Inc
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207773
- Marketing start
- Listing expires
- Other FDA classes
- Tetracyclines (Chemical structure)
- Identifiers
- Product ID 72578-001_6fd4ce71-429d-4bbb-a8e6-afd510319830SPL ID 6fd4ce71-429d-4bbb-a8e6-afd510319830SPL set ID 763997f0-b35c-43cb-a792-3e0bae589536RxCUI 1650143UNII 19XTS3T51U
- Pharmacologic class
- Tetracycline-class Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472578000101followed by a unit qualifier and the quantityPackage 72578-0001-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate tablets and other antibacterial drugs, doxycycline hyclate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Treatment Doxycycline hyclate tablets are indicated for the treatment of the following infections: Rocky Mountain spott…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 207773
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Doxycycline hyclate | Doxycycline hyclate 100 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1104 |
| Doxycycline Hyclate | Doxycycline hyclate 100 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-2113 |
| Doxycycline Hyclate | Doxycycline hyclate 100 mg/1 | TabletOral | RedPharm Drug, Inc. | 67296-1431 |
| Doxycycline Hyclate | Doxycycline hyclate 100 mg/1 | TabletOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8529 |